agilon health, inc. (AGL)

NYSE: AGL · USD

$90.9

+0.21 (+0.2%)· Recorded snapshot

Market cap	1.5B
Revenue (ttm)	5.9B
Net income (ttm)	-232.2M
EPS (ttm)	-$14.0
Shares out	16.8M
P/E (forward)	56.2x
Volume	202,322
Beta	2.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.9B
Net income (ttm): -232.2M
EPS (ttm): -$14.0
P/E (forward): 56.2x
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E56.2

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-78.9

P25 n/aP50 n/aP75 n/a

ROIC-44.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AGL indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001831097
Company name	agilon health, inc.
Country	United States
Country code	US
CUSIP number	00857U206
Earnings date	2026-11-04
Earnings time	amc
Employees	856
Employees change	-220
Employees growth	-20.45%
Enterprise value	$1.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2021-04-15
Is primary listing	Yes
Is SPAC	No
ISIN number	US00857U2069
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2026-03-31
Last stock split type	Reverse
Market cap	$1.5B
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$90.86
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	AGL
U.S. state	Ohio
Website	https://www.agilonhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-15.38%
EV/Sales	0.24x
FCF / EV yield	-6.03%
FCF yield	-5.44%
Forward EV/Sales	0.23x
Forward P/E	56.2x
Forward P/S	0.26x
Industry forward P/E	14.95x
Industry P/E	18.37x
P/B ratio	6.69x
P/S ratio	0.26x
Price / tangible book value	9.32x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.29%
EBITDA margin	-4.05%
Gross margin	0.23%
Operating margin	-4.29%
Pretax margin	-4.23%
Profit margin	-3.92%
Profit per employee	$-271,282
Profitable quarters	2
Revenue per employee	$6.9M
ROA	-9.61%
ROA (5Y)	-12.53%
ROCE	-91.07%
ROE	-78.94%
ROE (5Y)	-61.32%
ROIC	-44.65%
SBC / revenue	0.8%
Tax / revenue	0.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-64.63%
EPS growth quarters	2
EPS growth years	0
Gross profit growth 3Y	-56.02%
Gross profit growth 5Y	-30.04%
Net income growth (QoQ)	-63.29%
Net income growth quarters	2
Net income growth years	0
Revenue growth	0.32%
Revenue growth (Q)	7.15%
Revenue growth (QoQ)	5.23%
Revenue growth 3Y	22.91%
Revenue growth 5Y	30.81%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-12.7M
Depreciation and amortization	$14.4M
EBIT	$-254.1M
EBITDA	$-239.7M
EPS	$-13.97
FCF per share	$-5.06
Financing cash flow	$-769,000
Free cash flow	$-85M
Free cash flow minus SBC	$-132.1M
Gross profit	$13.8M
Income taxes	$646,000
Investing cash flow	$80.4M
Net borrowing	$-3.5M
Net cash flow	$7.4M
Net income	$-232.2M
Operating cash flow minus SBC	$-119.4M
Operating income	$-254.1M
Revenue	$5.9B
Stock-based compensation	$47.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.85
Book value per share	$13.56
Debt / equity	0.15
Interest coverage	-36.44
Long-term assets	$172.8M
Long-term liabilities	$51.5M
Net cash (debt)	$152.2M
Net cash / market cap	9.75%
Net cash growth	-46.72%
Net debt / equity	-0.67
Piotroski F-Score	3
Property, plant and equipment	$29.4M
Shareholders' equity	$227.5M
Tangible book value	$167.4M
Tangible book value per share	$9.97
Total assets	$1.6B
Total cash	$185.6M
Total debt	$33.4M
Total liabilities	$1.4B
WACC	20.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	3.58
Current assets	$1.4B
Current liabilities	$1.3B
Current ratio	1.08
Net working capital	$-64.5M
Quick ratio	0.98
Working capital	$106.2M
Working capital turnover	38.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.57%
Dividend yield	0%
Shareholder yield	-0.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$80.47
1D price change	0.23%
1M price change	13.03%
1M total return	13.03%
1W price change	-0.51%
1W total return	-0.51%
1Y price change	285.71%
1Y return CAGR	286.07%
1Y total return	285.71%
20-day SMA	$87.15
200-day SMA	$64.38
3M price change	-7.29%
3M total return	-7.29%
3Y price change	-79.79%
3Y return CAGR	-41.31%
3Y total return	-79.79%
50-day SMA	$88.18
50-day SMA vs 200-day SMA	50over200
52-week high	$133.04
52-week high date	2026-07-17
52-week low	$7.48
52-week low date	2026-03-31
5Y price change	-84.7%
5Y return CAGR	-31.3%
5Y total return	-84.7%
6M price change	260.39%
6M total return	260.39%
All-time high	$1,120.75
All-time high date	2021-06-18
All-time low	$7.48
All-time low date	2026-03-31
Average true range (ATR)	$4.87
Average volume	186.5K
Beta (1Y)	6.51
Beta (2Y)	2.66
Beta (5Y)	2.99
Change from 52-week high	-31.7%
Change from 52-week low	1,114.71%
Change from all-time high	-91.86%
Change from all-time low	1,119.92%
Change from open	-0.78%
Day's gap	1.01%
Dollar volume	$18.4M
High price	$93.34
Low price	$90.86
Monthly RSI	47.74
Open price	$91.57
Position in 52-week range	0%
Premarket change	-0.47%
Premarket close	$90.65
Premarket price	$90.22
Premarket volume	7.6K
Previous close	$90.65
Price vs 150-day SMA	13.4%
Price vs 20-day SMA	4.7%
Price vs 200-day SMA	41.75%
Price vs 50-day SMA	3.48%
Relative volume	1.09
Return from IPO open	-86.84%
Return from IPO price	304.09%
RSI	57.44
Sharpe ratio	1.44
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	0.08
Sortino ratio	3.33
Sortino ratio (3Y)	0.23
Sortino ratio (5Y)	0.2
Volume	202.3K
Weekly RSI	58.11
YTD price change	429.97%
YTD total return	429.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10.9M
Float percentage	65.08%
Shares change (QoQ)	3.31%
Shares change (YoY)	0.57%
Shares held by insiders	2.25%
Shares held by institutions	64.98%
Shares outstanding	16.8M
Short % of float	9.23%
Short % of shares	6.01%
Short ratio	4.4 days

Deeper analysis on AGL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AGL report

Is a complete AGL research report available?

No complete published report is available for agilon health, inc. (AGL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

agilon health, inc. (AGL)

Price

Financial snapshot

Fair-value bridge

Latest news · AGL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AGL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AGL

Frequently asked questions